In 2020, the world curled up in shock, and in 2021 it bowed its head in hope. Will 2022 bring some superficial normality? Probably yes, if we accept the coronavirus and its new incarnation of Omicron, it will become part of our new normal.

Even if the third wave led by the Omicron variant threatens to be summoned, the world will still leave this new normal physical and mental scar in the cruel second wave. But experts say that our immune system is learning.

“As we live with the new coronavirus longer, more and more people will be infected and develop natural immunity to it. Secondly, vaccination will greatly reduce the chances of death and hospitalization,” a vaccine expert and Scientist Dr. Gagandeep Kang told News18.com.

“Suppose our body is a newborn child,” explained a microbiologist at Vellore Christian Medical School. “The child will be infected with more viruses in the first few years because he/she will encounter more pathogens in the atmosphere. But as he/she grows up and the body has immunity, the child will not often I’m sick.” Similarly, as the human body continues to be exposed to different strains of coronavirus, it will expand the body’s immune response, that point, will make Covid-19 as casual as “cold and flu”.

Although most mutations may not matter to most people, health experts point out that vulnerable people still face challenges—unvaccinated, elderly people, and people with chronic diseases.

The following are the greatness, beauty and severity of the fight against Covid-19.

Great: we know more and better than 2020
Although the first year of the pandemic is a final word, 2021 will provide the medical community with more certainty in designing treatment plans. By 2022, Covid-19 treatment may become more systematic. Clinicians are also more confident unless there is a completely new mutant (very low probability).

In early 2020, the first choice of treatment includes the use of the antimalarial drug hydroxychloroquine (HCQ), the anti-HIV drug ritonavir, and plasma therapy. By mid-2020, Indian drugmakers have launched the experimental drug Remdesivir, followed by the Japanese flu drug Fabiravir. Doctors started using Roche’s Actemra, also known as tocilizumab and the antiparasitic drug ivermectin. In 2021, remdesivir, plasma and HCQ proved to be ineffective in the treatment of Covid-19, and steroids become essential in severe cases. The medical community understands the correct time to use ventilators, blood thinners, and tocilizumab, and the best time to prescribe ivermectin and favipiravir.

“We started with the symptomatic treatment of Covid-19, where dehydration and blood thinning are the key. Later, we learned about the use of steroids in severe cases and when we should put patients on ventilators,” Intensive Care Medicine, Holy Family Hospital, Delhi Section Director Sumit Ray said.

Complete News Source : NEWS18